Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

REVascularization In Large VEssel Occlusion for Acute Ischemic Stroke

NCT: NCT07216170 · NOT_YET_RECRUITING

NCT IDNCT07216170
StatusNOT_YET_RECRUITING
Start Date2026-12
Completion2027-12

Brief Summary

The objective of this study is to evaluate the safety and effectiveness of the SOFIA Flow 88 Aspiration Catheter for treatment of acute ischemic stroke.

Frequently Asked Questions

What is REVascularization In Large VEssel Occlusion for Acute Ischemic Stroke?

REVascularization In Large VEssel Occlusion for Acute Ischemic Stroke is a clinical trial registered under NCT07216170. Current status: NOT_YET_RECRUITING.

What is the status of NCT07216170?

The current status of NCT07216170 (REVascularization In Large VEssel Occlusion for Acute Ischemic Stroke) is: NOT_YET_RECRUITING.

When did REVascularization In Large VEssel Occlusion for Acute Ischemic Stroke start?

REVascularization In Large VEssel Occlusion for Acute Ischemic Stroke started on 2026-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑